Literature DB >> 11866080

Evaluation of the risk factors of avascular necrosis of the femoral head in developmental dysplasia of the hip in infants younger than 18 months of age.

Haluk Aguş1, Hakan Omeroğlu, Hakan Uçar, Ali Biçimoglu, Yücel Türmer.   

Abstract

Sixty-seven dysplastic hips of 54 infants with an average age of 11.9 months were treated by the same surgical technique, including iliopsoas and adductor tenotomies via medial approach and arthrography for verification of the concentric reduction. The average follow-up period was 44.5 months. The rate of overall avascular necrosis (AVN) was 27% and that of severe AVN was 7%. With the numbers available in the study, a statistically significant relationship could not be found between the rate and severity of AVN and several preoperative and intraoperative components such as age, sex, side, dislocation grade, development of the ossific nucleus and qualitv of intraoperative reduction. Nevertheless, hips of infants treated between 13 months and 15 months of age, hips of male patients and left hips had slightly higher ratios of ischemic changes that were not statistically significant.

Entities:  

Mesh:

Year:  2002        PMID: 11866080     DOI: 10.1097/01202412-200201000-00007

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  11 in total

1.  Developmental dysplasia of the hip: open reduction as a risk factor for substantial osteonecrosis.

Authors:  G B Firth; A J F Robertson; A Schepers; L Fatti
Journal:  Clin Orthop Relat Res       Date:  2010-06-08       Impact factor: 4.176

Review 2.  Is Age or Surgical Approach Associated With Osteonecrosis in Patients With Developmental Dysplasia of the Hip? A Meta-analysis.

Authors:  Eduardo N Novais; Mary K Hill; Patrick M Carry; Patricia C Heyn
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

3.  Does open reduction of the developmental dislocated hip increase the risk of osteonecrosis?

Authors:  Renata Pospischill; Julia Weninger; Rudolf Ganger; Johannes Altenhuber; Franz Grill
Journal:  Clin Orthop Relat Res       Date:  2011-06-04       Impact factor: 4.176

4.  The presence of an ossific nucleus does not protect against osteonecrosis after treatment of developmental dysplasia of the hip.

Authors:  Andreas Roposch; Odeh Odeh; Andrea S Doria; John H Wedge
Journal:  Clin Orthop Relat Res       Date:  2011-02-11       Impact factor: 4.176

5.  Radiographic outcome of children older than twenty-four months with developmental dysplasia of the hip treated by closed reduction and spica cast immobilization in human position: a review of fifty-one hips.

Authors:  YiQiang Li; YueMing Guo; XianTao Shen; Hang Liu; HaiBo Mei; HongWen Xu; Federico Canavese
Journal:  Int Orthop       Date:  2019-04-12       Impact factor: 3.075

6.  Correlation between avascular necrosis and the presence of the ossific nucleus when treating developmental dysplasia of the hip.

Authors:  Sabit Sllamniku; Cen Bytyqi; Ardiana Murtezani; Emir Q Haxhija
Journal:  J Child Orthop       Date:  2013-10-22       Impact factor: 1.548

Review 7.  [Indications and results of corrective pelvic osteotomies in developmental dysplasia of the hip].

Authors:  M Jäger; B Westhoff; C Zilkens; K Weimann-Stahlschmidt; R Krauspe
Journal:  Orthopade       Date:  2008-06       Impact factor: 1.087

8.  A Comparative Study of Clinical and Radiological Outcomes of Open Reduction Using the Anterior and Medial Approaches for the Management of Developmental Dysplasia of the Hip.

Authors:  Omer Naci Ergin; Mehmet Demirel; Emre Meric; Volkan Sensoy; Fuat Bilgili
Journal:  Indian J Orthop       Date:  2020-06-20       Impact factor: 1.251

9.  Risk factors for avascular necrosis after closed reduction for developmental dysplasia of the hip.

Authors:  Mathew D Schur; Christopher Lee; Alexandre Arkader; Anthony Catalano; Paul D Choi
Journal:  J Child Orthop       Date:  2016-05-13       Impact factor: 1.548

Review 10.  Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis.

Authors:  Rafal Niziol; Michael Elvey; Evangelia Protopapa; Andreas Roposch
Journal:  BMC Musculoskelet Disord       Date:  2017-04-20       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.